Beyond Divestitures: How Flexible Merger Remedies Are Reshaping Global Deal Strategy

Executive Summary

Antitrust authorities in the United States, Europe, and Asia are rethinking how they address competition concerns in cross-border mergers. A growing openness to behavioral and hybrid remedies — rather than outright divestitures — is reshaping how multinational companies plan and execute global deals. This shift carries significant implications for foreign direct investment (FDI), market access, supply chain integration, and the broader interplay between competition policy and industrial strategy.

Introduction

For decades, structural remedies — primarily divestitures — have been the default response to antitrust concerns in major international transactions. But the regulatory landscape is evolving. From Washington to Beijing, enforcement agencies are signaling greater willingness to accept behavioral commitments, including technology licensing, network investment pledges, pricing safeguards, and even content neutrality requirements.

These developments are not merely legal nuances. They influence cross-border commerce, investment confidence, and the global restructuring of supply chains. Companies pursuing ambitious international partnerships must now treat remedies as a strategic component of deal architecture, not an afterthought.

Main Analysis

Recent enforcement data illustrate a pronounced shift. In the United States, the Department of Justice (DOJ) and Federal Trade Commission (FTC) have resolved 16 merger investigations with remedies during the first 18 months of the current administration — a sharp contrast with the previous administration's single consent decree in the same context. While structural remedies remain the stated preference, agencies have accepted hybrid and behavioral terms in notable matters.

For example, the HPE/Juniper transaction combined a divestiture with a license to Juniper's wireless LAN software source code. In Omnicom's acquisition of IPG, the FTC imposed behavioral restrictions preventing collusion or advertising direction based on political viewpoints. Agency leaders have publicly encouraged early remedy engagement, signaling a departure from the previous 'litigate the fix' approach.

In the United Kingdom, the Competition and Markets Authority (CMA) has formalized a more flexible stance. Its revised merger remedies guidance, issued in December 2025, expands the scope for behavioral commitments. This is seen as a concrete outcome of the Vodafone/Three merger, where network investment commitments, tariff caps, and wholesale access terms were accepted — the first such behavioral package in a Phase 2 review since 2020.

The European Commission is updating its merger control guidelines to give greater weight to dynamic efficiencies, innovation, and scale. Although the draft guidelines do not directly address remedies, they could reshape how structural and nonstructural fixes are designed and evaluated. Twenty Commission clearances with remedies since 2024 have all been structural, but Europe's overall direction points toward more holistic and forward-looking assessments.

In Asia Pacific, behavioral remedies have long coexisted with structural ones, often reflecting local industrial policy priorities. China remains the most consequential jurisdiction. Its legal mandate to consider a transaction's impact on the national economy means regulators often require commitments beyond standard competition concerns. Behavioral remedies offer a flexible tool to address these China-specific issues without destroying deal value.

Countries such as South Korea and the Philippines are increasingly adopting behavioral commitments in digital platform mergers, including e-commerce, online streaming, and digital payments. Vietnam and Indonesia have favored softer, reporting-type remedies. Japan continues to prefer structural measures, but it permits behavioral remedies for licensing IP or ensuring supply to third parties. India is blending both approaches, reflecting a pragmatic, case-by-case philosophy.

Global Trade Impact

Flexible remedies are lowering regulatory barriers to cross-border mergers, enabling companies to preserve integrated operations and supply chain synergies that may otherwise be fractured by forced divestitures. This supports more efficient global manufacturing, logistics, and distribution networks. For exporters, importers, and trade-dependent businesses, greater certainty in deal approval encourages deeper international collaboration and capital investment.

The trend also signals a convergence between antitrust analysis and industrial policy. Regulators are now weighing efficiency gains, customer benefits, and broader policy objectives such as technological sovereignty, resilience, and digital infrastructure development. This means merger control is no longer a domain solely about market competition; it is increasingly intertwined with trade policy and global economic security.

For cross-border e-commerce and digital trade, behavioral remedies may prove especially relevant. Markets defined by platform ecosystems, data access, and innovation dynamics require nuanced solutions that a simple divestiture cannot provide. The willingness to consider behavioral conditions helps preserve innovation cycles and global market integration.

Strategic Insights

Companies engaged in global mergers and acquisitions should now consider remedies at the earliest stages of transaction planning. Key strategic takeaways include:

• Early Engagement: Regulators are more responsive to remedy proposals made during the review process rather than in litigation. Early, transparent dialogue can shorten timelines and reduce risk.
• Consistent Advocacy, Tailored Commitments: A common narrative emphasizing efficiencies, customer benefits, and policy alignment should be adapted to jurisdiction-specific expectations.
• Hybrid Solutions: Combining divestitures with licensing, infrastructure investment, or access commitments can preserve more value and satisfy multiple regulators.
• China-Specific Strategy: Given China's expansive review authority, behavioral remedies are essential to address industrial policy and national economy concerns.
• Digital Platform Preparedness: As Asia's digital economy matures, behavioral remedies are becoming standard for platform transactions, affecting both e-commerce and the digital infrastructure that underpins trade.

The broader lesson is that remedies are a governance tool, not just a compliance requirement. Used strategically, they can position companies as constructive partners in the policy objectives of global regulators.

Future Outlook

Over the next three to five years, flexible merger remedies will likely become more widespread. The European Commission's updated merger guidelines, expected by the end of 2026, will likely reinforce a more dynamic, efficiencies-focused assessment, promoting behavioral and hybrid remedies in cases involving innovation, scale, and investment. In the United States, the current administration's pragmatic approach may persist, underpinned by the desire to facilitate pro-competitive business combinations while enforcing fundamental rules.

In Asia, the normalization of behavioral remedies will make cross-border M&A a more viable route for corporate expansion. Sectors critical to global supply chains — semiconductors, electronics, telecommunications, and industrial automation — may see heightened deal activity as companies align with regulatory expectations on investment and access.

Longer-term, the integration of antitrust and industrial objectives could redefine global trade relationships. Flexible remedies may serve as a non-tariff instrument, helping multinational enterprises navigate protectionist pressures and maintain access to key markets. The ability to negotiate sophisticated remedies will become a core competency for corporate strategists, trade lawyers, and dealmakers.

The evolving approach to merger enforcement — moving beyond divestitures — represents a significant mutation in the architecture of international commerce. Businesses, investors, and policymakers should monitor these trends closely, as the new balance between structure and conduct could shape the global economy for the next decade.

Key Takeaways

• Both U.S. antitrust agencies have shown significantly more willingness to accept merger remedies under the current administration.
• The UK CMA has formalized a flexible, behavior-inclusive remedy approach.
• The European Commission is shifting toward efficiencies and innovation considerations that will likely accommodate nonstructural fixes.
• China remains a critical jurisdiction where behavioral remedies help resolve national economy and industrial policy concerns.
• Businesses should prepare remedy strategies early and maintain a consistent cross-border line of reasoning.

Sources

The insights for this article are based on and adapted from: Skadden, Arps, Slate, Meagher & Flom LLP. 'Beyond Divestitures: The Global Shift Toward More Flexible Merger Remedies.' June 2026. https://www.skadden.com/insights/publications/2026/06/insights-june-2026/beyond-divestitures-the-global-shift